Our previous studies using the skin carcinogenesis model revealed that during early tumor promotion, the tumor suppressor p53 was activated after tumor promoter treatment, and a fraction of p53 translocated into mitochondria which preceded its nuclear translocation. Here, TP53 is linked to neoplasm.